Inventor · disambiguated record
Cristina Lecci
Also filed as: LECCI CRISTINA
13 granted patents·3 pending applications·25 citations·filing 2011–2022
88Inventor score
Files withPADLOCK THERAPEUTICS INC7VIFOR INT AG4RAZE THERAPEUTICS INC2FACIO INTELLECTUAL PROPERTY B V1TREU MATTHIAS1
Top patents by PatentIndex Score
16 records- 0190US10364239B2Ferroportin inhibitorsVIFOR INT AG·Filed 2016·Granted Jul 30, 2019·6 cites·21 claims
- 0284US10738041B2Ferroportin inhibitorsVIFOR (INTERNATIONAL) AG·Filed 2016·Granted Aug 11, 2020·3 cites·18 claims
- 0379US11370792B2Caffeine inhibitors of MTHFD2 and uses thereofRAZE THERAPEUTICS INC·Filed 2016·Granted Jun 28, 2022·2 cites·20 claims
- 0478US11198681B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Dec 14, 2021·4 cites·15 claims
- 0577US8546443B2Benzylic oxindole pyrimidinesTREU MATTHIAS·Filed 2011·Granted Oct 1, 2013·5 cites·40 claims
- 0672US11066399B2Ferroportin inhibitorsVIFOR INT AG·Filed 2020·Granted Jul 20, 2021·0 cites·6 claims
- 0771US11026937B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·7 claims
- 0871US2022363675A1Novel Ferroportin InhibitorsVIFOR INT AG·Filed 2021·Application pending·0 cites
- 0970US9963448B2Bicyclic inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·2 cites·20 claims
- 1068US11001579B2Ferroportin inhibitorsVIFOR INT AG·Filed 2019·Granted May 11, 2021·0 cites·11 claims
- 1168US10703741B2Covalent inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jul 7, 2020·1 cites·13 claims
- 1266US9765093B2Aza-benzimidazole inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted Sep 19, 2017·1 cites·17 claims
- 1364US12187728B2Caffeine inhibitors of MTHFD2 and uses thereofRAZE THERAPEUTICS INC·Filed 2022·Granted Jan 7, 2025·0 cites·16 claims
- 1462US11897866B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2021·Granted Feb 13, 2024·0 cites·15 claims
- 1560US2021299115A1Heteroaryl inhibitors of pad4PADLOCK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1642US2023271953A1Novel compounds for treatment of diseases related to DUX4 expressionFACIO INTELLECTUAL PROPERTY B V·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cristina Lecci files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →